- Home
- LEDS vs APM Comparison
LEDS vs APM Comparison
Compare LEDS & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEDS
- APM
- Stock Information
- Founded
- LEDS 2005
- APM 2010
- Country
- LEDS Taiwan
- APM United Kingdom
- Employees
- LEDS N/A
- APM N/A
- Industry
- LEDS Semiconductors
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- LEDS Technology
- APM Health Care
- Exchange
- LEDS Nasdaq
- APM Nasdaq
- Market Cap
- LEDS 16.1M
- APM 18.9M
- IPO Year
- LEDS 2010
- APM 2018
- Fundamental
- Price
- LEDS $1.70
- APM $1.85
- Analyst Decision
- LEDS
- APM
- Analyst Count
- LEDS 0
- APM 0
- Target Price
- LEDS N/A
- APM N/A
- AVG Volume (30 Days)
- LEDS 23.0K
- APM 20.3M
- Earning Date
- LEDS 07-11-2025
- APM 04-30-2025
- Dividend Yield
- LEDS N/A
- APM N/A
- EPS Growth
- LEDS N/A
- APM N/A
- EPS
- LEDS N/A
- APM N/A
- Revenue
- LEDS $31,108,000.00
- APM N/A
- Revenue This Year
- LEDS N/A
- APM N/A
- Revenue Next Year
- LEDS N/A
- APM N/A
- P/E Ratio
- LEDS N/A
- APM N/A
- Revenue Growth
- LEDS 485.62
- APM N/A
- 52 Week Low
- LEDS $0.92
- APM $0.46
- 52 Week High
- LEDS $3.16
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- LEDS 42.19
- APM 50.26
- Support Level
- LEDS $1.61
- APM $1.64
- Resistance Level
- LEDS $1.74
- APM $1.90
- Average True Range (ATR)
- LEDS 0.14
- APM 0.36
- MACD
- LEDS 0.00
- APM -0.06
- Stochastic Oscillator
- LEDS 20.93
- APM 18.38
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.